Publikationen

_80.

_{Hoffmann A, Dege T, Kunze R, Ernst AS, Lorenz H, Böhler LI, Korff T, Marti HH, Heiland S, Bendszus M, Helluy X, Pham M. Early Blood-Brain Barrier Disruption in Ischemic Stroke Initiates Multifocally Around Capillaries/Venules. Stroke. 2018 May 14. pii: STROKEAHA.118.020927. doi: 10.1161/STROKEAHA.118.020927. [Epub ahead of print]}

_79.

_{Hefter D, Marti HH, Gass P, Inta D. Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia. Front Psychiatry. 2018 Mar 29;9:106. doi: 10.3389/fpsyt.2018.00106. eCollection 2018.}

_78.

_{Himmels P, Paredes I, Adler H, Karakatsani A, Luck R, Marti HH, Ermakova O, Rempel E, Stoeckli ET, Ruiz de Almodóvar C. Motor neurons control blood vessel patterning in the developing spinal cord. Nat Commun. 2017 Mar 6;8:14583. doi: 10.1038/ncomms14583.}

_77.

_{Barteczek P, Li L, Ernst AS, Böhler LI, Marti HH, Kunze R. Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke. J Cereb Blood Flow Metab. 2017 Jan;37(1):291-306. Epub 2016 Jan 8.}

_76.

_{Gruneberg D, Montellano FA, Plaschke K, Li L, Marti HH, Kunze R. Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion. Exp Neurol. 2016 Dec;286:93-106. doi: 10.1016/j.expneurol.2016.10.001.}

_75.

_{Li L, Saliba P, Reischl S, Marti HH, Kunze R. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner. Neurobiol Dis. 2016 Jul;91:221-35. doi: 10.1016/j.nbd.2016.03.018. Epub 2016 Mar 19.}

_74.

_{Lin-Holderer J, Li L, Gruneberg D, Marti HH, Kunze R. Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway. Neuropharmacology. 2016 Jun;105:228-40. doi: 10.1016/j.neuropharm.2016.01.023. Epub 2016 Jan 19.}

_73.

_{Hoffmann A, Kunze R, Helluy X, Milford D, Heiland S, Bendszus M, Pham M, Marti HH. High-Field MRI Reveals a Drastic Increase of Hypoxia-Induced Microhemorrhages upon Tissue Reoxygenation in the Mouse Brain with Strong Predominance in the Olfactory Bulb. PLoS One. 2016 Feb 10;11(2):e0148441. doi: 10.1371/journal.pone.0148441. eCollection 2016.}

_72.

_{Lelli A, Nolan KA, Santambrogio S, Gonçalves AF, Schönenberger MJ, Guinot A, Frew IJ, Marti HH, Hoogewijs D, Wenger RH. Induction of long noncoding RNA MALAT1 in hypoxic mice. Hypoxia (Auckl). 2015 Oct 8;2015(3):45-52. doi: 10.2147/HP.S90555.}

_71.

_{Kunze R, Urrutia A, Hoffmann A, Liu H, Helluy X, Pham M, Reischl S, Korff T, Marti HH. Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity. Exp Neurol. 2015 Apr;266:99-111. doi: 10.1016/j.expneurol.2015.02.022. Epub 2015 Feb 25.}

_70.

_{Lee H, Lee JK, Park MH, Hong YR, Marti HH, Kim H, Okada Y, Otsu M, Seo EJ, Park JH, Bae JH, Okino N, He X, Schuchman EH, Bae JS, Jin HK. Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons. Nat Commun. 2014 Nov 24;5:5514. doi: 10.1038/ncomms6514.}

_69.

_{Reischl S, Li L, Walkinshaw G, Flippin LA, Marti HH, Kunze R.  Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke. PLoS One. 2014 Jan 7;9(1):e84767. doi: 10.1371/journal.pone.0084767.}

_68.

_{Corcoran A, Kunze R, Harney SC, Breier G, Marti HH, O'Connor JJ. A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity. Hippocampus. 2013 Oct;23(10):861-72. doi: 10.1002/hipo.22142. Epub 2013 May 15.}

_67.

_{Religa P, Cao R, Religa D, Xue Y, Bogdanovic N, Westaway D, Marti HH, Winblad B, Cao Y. VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival. Sci Rep. 2013 Jun 24;3:2053. doi: 10.1038/srep02053.}

_66.

_{Kaufmann MR, Barth S, Konietzko U, Wu B, Egger S, Kunze R, Marti HH, Hick M, Müller U, Camenisch G, Wenger RH. Dysregulation of Hypoxia-Inducible Factor by Presenilin/γ-Secretase Loss-of-Function Mutations. J Neurosci. 2013 Jan 30;33(5):1915-26. doi: 10.1523/JNEUROSCI.3402-12.2013.}

_65.

_{Kunze R, Zhou W, Veltkamp R, Wielockx B, Breier G, Marti HH. Neuron-Specific Prolyl-4-Hydroxylase Domain 2 Knockout Reduces Brain Injury After Transient Cerebral Ischemia. Stroke. 2012 Oct;43(10):2748-56. Epub 2012 Aug 28.}

_64.

_{Cvetanovic M, Patel JM, Marti HH, Kini AR, Opal P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nat Med. 2011 Oct 16;17(11):1445-7. doi: 10.1038/nm.2494.}

_63.

_{Rabie T, Kunze R, Marti HH. Impaired hypoxic response in senescent mouse brain. Int J Dev Neurosci. 2011 Oct;29(6):655-61. Epub 2011 Jun 16.}

_{Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, Vogel AB, Marti HH, Al-Abed Y, Planz O, Schwaninger M. Influenza virus infection aggravates stroke outcome. Stroke. 2011 Mar;42(3):783-91. Epub 2011 Feb 3.}

_61.

_{Sun L, Zhou W, Heiland S, Marti HH, Veltkamp R. A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats. Brain Res. 2011 Jan 12;1368:346-54. Epub 2010 Oct 23.}

_60.

_{Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab. 2010 Sep;30(9):1651-60. Epub 2010 Apr 28.}

_59.

_{Bauer AT, Bürgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010 Apr;30(4):837-48. Epub 2009 Dec 9.}

_58.

_{Rabie T, Mühlhofer W, Bruckner T, Schwab A, Bauer AT, Zimmermann M, Bonke D, Marti HH, Schenkel J. Transient protective effect of B-vitamins in experimental epilepsy in the mouse brain. J Mol Neurosci. 2010 May;41(1):74-9. Epub 2009 Sep 24.}

_57.

_{Lubjuhn J, Gastens A, von Wilpert G, Bargiotas P, Herrmann O, Murikinati S, Rabie T, Marti HH, Amende I, Hampton TG, Schwaninger M. Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery. J Neurosci Methods. 2009 Oct 30;184(1):95-103. Epub 2009 Aug 4. Erratum in: J Neurosci Methods. 2010 Jan 30;186(1):140. Marti, Hugo [corrected to Marti, Hugo H].}

_56.

_{Rabie T, Marti HH. Brain protection by erythropoietin: a manifold task. Physiology (Bethesda). 2008 Oct;23:263-74. Review.}

_55.

_{Plaschke K, Staub J, Ernst E, Marti HH. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol. 2008 Dec;214(2):285-92. Epub 2008 Sep 11.}

_54.

_{Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, Rabie T, Kaden S, Gröne HJ, Hämmerling GJ, Arnold B, Ganss R. Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature. 2008 May 15;453(7193):410-4. Epub 2008 Apr 16.}

_53.

_{Sun L, Marti HH, Veltkamp R. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia. Stroke. 2008 Mar;39(3):1000-6. Epub 2008 Jan 31.}

_52.

_{Heinzer S, Kuhn G, Krucker T, Meyer E, Ulmann-Schuler A, Stampanoni M, Gassmann M, Marti HH, Müller R, Vogel J. Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. Neuroimage. 2008 Feb 15;39(4):1549-58. Epub 2007 Nov 12.}

_51.

_{Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum. 2007 Dec;56(12):4203-15.}

_50.

_{Beynon C, Sun L, Marti HH, Heiland S, Veltkamp R. Delayed hyperbaric oxygenation is more effective than early prolonged normobaric hyperoxia in experimental focal cerebral ischemia. Neurosci Lett. 2007 Oct 2;425(3):141-5. Epub 2007 Aug 1.}

_49.

_{Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, Fischer S. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol. 2007 Jul;212(1):236-43.}

_48.

_{Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J Neurosci Res. 2007 Mar;85(4):740-7.}

_47.

_{Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 2007 Jan 10;27(2):304-7.}

_46.

_{Kilic U, Kilic E, Järve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci. 2006 Nov 29;26(48):12439-46.}

_45.

_{Veltkamp R, Sun L, Herrmann O, Wolferts G, Hagmann S, Siebing DA, Marti HH, Veltkamp C, Schwaninger M. Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res. 2006 Aug 30;1107(1):185-91. Epub 2006 Jul 10.}

_44.

_{Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006 Jun;20(8):1185-7. Epub 2006 Apr 26.}

_43.

_{Veltkamp R, Bieber K, Wagner S, Beynon C, Siebing DA, Veltkamp C, Schwaninger M, Marti HH. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res. 2006 Mar 3;1076(1):231-7. Epub 2006 Feb 9.}

_42.

_{Schaffer L, Marti HH. Comments on Point-Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume". J Appl Physiol. 2006 Jan;100(1):366. No abstract available.}

_41.

_{Schäffer L, Vogel J, Breymann C, Gassmann M, Marti HH. Preserved placental oxygenation and development during severe systemic hypoxia. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R844-51. Epub 2005 Sep 29.}

_40.

_{Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, Nagel S, Schwab S, Schwaninger M. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke. 2005 Aug;36(8):1679-83. Epub 2005 Jul 14.}

_39.

_{Marti HH. Angiogenesis--a self-adapting principle in hypoxia. EXS. 2005;(94):163-80. Review.}

_38.

_{Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain. 2005 Jan;128(Pt 1):52-63. Epub 2004 Oct 27.}

_37.

_{Vogel J, Gehrig M, Kuschinsky W, Marti HH. Massive inborn angiogenesis in the brain scarcely raises cerebral blood flow. J Cereb Blood Flow Metab. 2004 Aug;24(8):849-59.}

_36.

_{Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol. 2004 Aug;207(Pt 18):3233-42. Review.}

_35.

_{Sköld MK, Marti HH, Lindholm T, Lindå H, Hammarberg H, Risling M, Cullheim S. Induction of HIF1alpha but not HIF2alpha in motoneurons after ventral funiculus axotomy-implication in neuronal survival strategies. Exp Neurol. 2004 Jul;188(1):20-32.}

_34.

_{Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W.Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells.J Cell Physiol. 2004 Mar;198(3):359-69.}

_33.

_{Schäffer L, Scheid A, Spielmann P, Breymann C, Zimmermann R, Meuli M, Gassmann M, Marti HH, Wenger RH. Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta. 2003 Nov;24(10):941-50.}

_32.

_{Katschinski DM, Marti HH, Wagner KF, Shibata J, Eckhardt K, Martin F, Depping R, Paasch U, Gassmann M, Ledermann B, Desbaillets I, Wenger RH. Targeted disruption of the mouse PAS domain serine/threonine kinase PASKIN. Mol Cell Biol. 2003 Oct;23(19):6780-9.}

_31.

_{Renner O, Tsimpas A, Kostin S, Valable S, Petit E, Schaper W, Marti HH. Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. Brain Res Mol Brain Res. 2003 May 12;113(1-2):44-51.}

_30.

_{Marti HH. Schlaganfälle behandeln mit Erythropoietin und dem Vaskulären Endothelialen Wachstumsfaktor (VEGF). Schweiz Med Forum. 2003 April 2;14:348-351}

_29.

_{Issbrücker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N, Clauss M. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 2003 Feb;17(2):262-4. Epub 2002 Dec 18.}

_28.

_{Marti HH. Vascular endothelial growth factor. Adv Exp Med Biol. 2002;513:375-94. Review.}

_27.

_{Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002 Nov;125(Pt 11):2549-57.}

_26.

_{Marti HH, Katschinski DM, Wagner KF, Schäffer L, Stier B, Wenger RH. Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Mol Endocrinol. 2002 Feb;16(2):234-43.}

_25.

_{Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2002 Jan;63(1):70-80.}

_24.

_{Magnanti M, Gandini O, Giuliani L, Gazzaniga P, Marti HH, Gradilone A, Frati L, Aglianò AM, Gassmann M. Erythropoietin expression in primary rat Sertoli and peritubular myoid cells. Blood. 2001 Nov 1;98(9):2872-4.}

_23.

_{Marti HH, Bernaudin M, Petit E, Bauer C. Neuroprotection and Angiogenesis: Dual Role of Erythropoietin in Brain Ischemia. News Physiol Sci. 2000 Oct;15:225-229.}

_22.

_{Pavlicek V, Marti HH, Grad S, Gibbs JS, Kol C, Wenger RH, Gassmann M, Kohl J, Maly FE, Oelz O, Koller EA, Schirlo C. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema. Eur J Appl Physiol. 2000 Apr;81(6):497-503.}

_21.

_{Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET, Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 2000 May;30(3):271-8.}

_{Marti H(J)H, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000 Mar;156(3):965-76.}

_19.

_{Marti HH, Risau W. Angiogenesis in ischemic disease. Thromb Haemost. 1999 Sep;82 Suppl 1:44-52. Review.}

_18.

_{Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J. 1999 Aug;13(11):1315-24.}

_17.

_{Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab. 1999 Jun;19(6):643-51.}

_16.

_{Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15809-14.}

_15.

_{Wenger RH, Marti HH, Bauer C, Gassmann M. Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. Int J Mol Med. 1998 Sep;2(3):317-24.}

_14.

_{Krieg M, Marti HH, Plate KH. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood. 1998 Nov 1;92(9):3388-93.}

_13.

_{Stallmach T, Karolyi L, Lichtlen P, Maurer M, Hebisch G, Joller H, Marti HH, Gassmann M. Fetuses from preeclamptic mothers show reduced hepatic erythropoiesis. Pediatr Res. 1998 Mar;43(3):349-54.}

_12.

_{Kvietikova I, Wenger RH, Marti HH, Gassmann M. The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 1997 Feb;51(2):564-6.}

_11.

_{Wenger RH, Kvietikova I, Rolfs A, Gassmann M, Marti HH. Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int. 1997 Feb;51(2):560-3.}

_10.

_{Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz O, Bauer C. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 1997 Feb;51(2):416-8.}

_9.

_{Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol. 1996 Oct;271(4 Pt 1):C1172-80.}

_8.

_{Wenger RH, Rolfs A, Marti HH, Guénet JL, Gassmann M. Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochem Biophys Res Commun. 1996 Jun 5;223(1):54-9.}

_7.

_{Gassmann M, Fandrey J, Bichet S, Wartenberg M, Marti HH, Bauer C, Wenger RH, Acker H. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2867-72.}

_6.

_{Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996 Apr;8(4):666-76.}

_5.

_{Wenger RH, Marti HH, Schuerer-Maly CC, Kvietikova I, Bauer C, Gassmann M, Maly FE. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase. Blood. 1996 Jan 15;87(2):756-61.}

_4.

_{Kvietikova I, Wenger RH, Marti HH, Gassmann M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 1995 Nov 25;23(22):4542-50.}

_3.

_{Wenger RH, Rolfs A, Marti HH, Bauer C, Gassmann M. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem. 1995 Nov 17;270(46):27865-70.}

_2.

_{Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3717-20.}

_1.

_{Marti HH, Jung HH, Pfeilschifter J, Bauer C. Hypoxia and cobalt stimulate lactate dehydrogenase (LDH) activity in vascular smooth muscle cells. Pflugers Arch. 1994 Dec;429(2):216-22.}

_7.

_{Wenger RH, Kurtcuoglu V, Scholz CC, Marti HH, Hoogewijs D. Frequently asked questions in hypoxia research. Hypoxia (Auckl). 2015 Sep 15;2015(3):35-43. doi: 10.2147/HP.S92198.}

_6.

_{Marti HH (2010). Altern und Tod. In: Taschenlehrbuch Physiologie (Gekle et al.). pp 611-615. Thieme (Stuttgart)}

_5.

_{Marti HH (2010). Leistungsphysiologie. In: Taschenlehrbuch Physiologie (Gekle et al.). pp 592-610. Thieme (Stuttgart)}

_4.

_{Marti HH, Bauer C (2006). Expression of erythropoietin and its receptor in the central nervous system. In: Erythropoietin and the nervous system (ed. Höke A). pp 15-31. Springer (New York)}

_3.

_{Issbrücker K, Marti HH, Clauss M (2004), Analysis of vascular permeability in vivo. In: Methods in Endothelial Cell Biology (ed. Augustin H). pp 223-232. Springer-Verlag (Berlin).}

_2.

_{Marti HH, Bernaudin M (2003). Function of erythropoietin in the brain. In: Erythropoietin: Molecular Biology and Clinical Use (ed. Jelkmann W). pp 195-215. FP Graham Publishing Co. (Johnson City).} 

_1.

_{Marti HH, Bauer C, Gassmann M (1997). Expression of erythropoietin in the mammalian brain. In: Internal Medicine and Endocrinology: Pathophysiological and Clinical Interactions (eds. Fabrini A, Santiemma V). pp 61-69. Centro Stampa d'Ateneo (Roma).}

_1.

_{Marti HH, Kunze R. Oxygen sensors and neuronal adaptation to ischemia. Oncotarget. 2017 Jan 10;8(2):1955-1956. doi: 10.18632/oncotarget.13938.}